Eversept Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,600	Closed	-$2.61M	–	63
2020 Q3	$2.61M	Buy	+5,600	New	+$2.61M	0.58%	30